Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FIBROGEN INC Director's Dealing 2024

Jun 7, 2024

34576_dirs_2024-06-06_b0331d56-fdd7-4961-99c7-e106419d336b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2024-06-05

Reporting Person: Lema Gerald (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-06-05 Stock Option (Right to Buy) $1.21 A 70000 Acquired 2034-06-04 Common Stock (70000) Direct

Footnotes

F1: Options vest on the earlier of June 16, 2025 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date.